Kittipong Maneechotesuwan
Bangkoknoi, BKK, 10700, Thailand
NCT Number: NCT00826163
We hypothesize that ongoing and more severe airway inflammation in COPD may result from the impairment in activation of innate immune response
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 3
Bangkoknoi, BKK, 10700, Thailand
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Inhaled budesonide 400 mcg twice a day for 2 weeks
Other names: Rhinocort
Time frame: 2 WEEKS
Time frame: 2 WEEKS
Mahidol University
Other
Innate Immune Responses in Chronic Obstructive Pulmonary Disease Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05984823
Chronic Disease, Chronic Obstructive Pulmonary Disease
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT05572333
COPD, Chronic Disease
Frankfurt, Germany
View Trial DetailsNCT03641235
Chronic Disease, Chronic Obstructive Pulmonary Disease
Bordeaux, France
View Trial DetailsNCT05984680
Chronic Disease, Chronic Obstructive Pulmonary Disease
Winston-Salem, North Carolina, United States
View Trial Details